Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CRI Worldwide, Lifetree CR Become CRI Lifetree | Contract Pharma

What are you searching for?

Sign in
Breaking News

CRI Worldwide, Lifetree CR Become CRI Lifetree

Combined company offers early stage research as well as Phase I-IV services

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

CRI Worldwide, which recently acquired Lifetree Clinical Research, has united the two companies under the new brand of CRI Lifetree. The combined company includes CRI’s expertise in psychiatry and in complex studies with Lifetree’s clinical trial management and site expertise in Phase I-III pain management and abuse liability studies.

“CRI Lifetree is grounded in sound science,” said Alice Jackson, CRI Lifetree’s president. “We give our clients the innovation they are looking for, from entrepreneurial first-in-human study design, to solutions for specialized human abuse liability research.”

“We’re off to a great start; the company is busier than ever,” commented Jeff Kinell, CRI Lifetree’s chief executive officer. “Since the acquisition, our clients have continued to receive the highest quality service and results, while enriching the early stage clinical research landscape for our sponsors.”

CRI Lifetree provides specialized, multi-therapeutic inpatient and outpatient early stage research as well as Phase I-IV services and access to specific patient populations for complex clinical research programs.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters